Indication
Diabetic ketoacidosis
Diabetic ketoacidosis is an acute, life-threatening metabolic emergency that predominantly affects individuals with type 1 diabetes mellitus, though it may also develop in patients with type 2 diabetes during acute illness or physiological stress. Read more about Diabetic ketoacidosis
13 drugs 5 manufacturers
Drugs that treat it
Common Diabetic ketoacidosis therapies.
NOVOLIN R (insulin regular, human)
NOVOLIN R (insulin regular, human)
MYXREDLIN (insulin regular, human in 0.9 % sodium chloride)
NOVOLIN R FLEXPEN (insulin regular, human)
NOVOLIN R FLEXPEN (insulin regular, human)
NOVOLIN R REGULAR U-100 INSULN (insulin regular, human)
HUMULIN R REGULAR U-100 INSULN (insulin regular, human)
NOVOLIN R REGULAR U-100 INSULN (insulin regular, human)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDiabetic ketoacidosis is an acute, life-threatening metabolic emergency that predominantly affects individuals with type 1 diabetes mellitus, though it may also develop in patients with type 2 diabetes during acute illness or physiological stress.
Arising from an absolute or relative insulin deficiency paired with an excess of counterregulatory hormones, the systemic endocrine condition triggers uncontrolled lipolysis and hepatic fatty acid oxidation.
It is classically characterized by the biochemical triad of hyperglycemia, high-anion-gap metabolic acidosis, and hyperketonemia.
Clinically, affected patients present with osmotic diuresis, dehydration, electrolyte derangements, nausea, abdominal pain, and Kussmaul respirations due to respiratory compensation for profound metabolic acidosis.
- nih.gov
Diabetic ketoacidosis is an acute, life-threatening metabolic emergency that predominantly affects individuals with type 1 diabetes mellitus, though it may also develop in patients with type 2 diabetes during acute illness or physiological stress
- nih.gov
Diabetic ketoacidosis is an acute, life-threatening metabolic emergency that predominantly affects individuals with type 1 diabetes mellitus, though it may also develop in patients with type 2 diabetes during acute illness or physiological stress
- nih.gov
Arising from an absolute or relative insulin deficiency paired with an excess of counterregulatory hormones, the systemic endocrine condition triggers uncontrolled lipolysis and hepatic fatty acid oxidation
- nih.gov
Arising from an absolute or relative insulin deficiency paired with an excess of counterregulatory hormones, the systemic endocrine condition triggers uncontrolled lipolysis and hepatic fatty acid oxidation
- nih.gov
It is classically characterized by the biochemical triad of hyperglycemia, high-anion-gap metabolic acidosis, and hyperketonemia
- nih.gov
It is classically characterized by the biochemical triad of hyperglycemia, high-anion-gap metabolic acidosis, and hyperketonemia
- nih.gov
Clinically, affected patients present with osmotic diuresis, dehydration, electrolyte derangements, nausea, abdominal pain, and Kussmaul respirations due to respiratory compensation for profound metabolic acidosis
- nih.gov
Clinically, affected patients present with osmotic diuresis, dehydration, electrolyte derangements, nausea, abdominal pain, and Kussmaul respirations due to respiratory compensation for profound metabolic acidosis
- nih.gov
Clinically, affected patients present with osmotic diuresis, dehydration, electrolyte derangements, nausea, abdominal pain, and Kussmaul respirations due to respiratory compensation for profound metabolic acidosis
Personalize your experience
Follow Diabetic ketoacidosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.